AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma
By Nicholas G. Miller
AbbVie agreed to acquire a device manufacturing facility in Tempe, Ariz., and the rights to the SmartDose 3.5 milliliter drug-delivery system from West Pharmaceutical Services as part of a deal worth $112.5 million.
Abbvie said the acquisition would significantly expand its drug-delivery manufacturing capacity and would support its production of current and next-generation immunology and neuroscience medicines.
The company said it would hire about 200 employees at the site and invest more than $175 m2illion for the acquisition as well as modernizing and integrating the facility.
West said it would continue to develop and manufacture all other versions of SmartDose, including the 10 milliliter SmartDose system.
The transaction is expected to close in the middle of this year.
Write to Nicholas G. Miller at nicholas.miller@wsj.com
(END) Dow Jones Newswires
January 12, 2026 06:40 ET (11:40 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States